BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24018334)

  • 1. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.
    Shiny A; Regin B; Balachandar V; Gokulakrishnan K; Mohan V; Babu S; Balasubramanyam M
    Cytokine; 2013 Nov; 64(2):564-70. PubMed ID: 24018334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD1 activators link innate immunity to insulin resistance.
    Schertzer JD; Tamrakar AK; Magalhães JG; Pereira S; Bilan PJ; Fullerton MD; Liu Z; Steinberg GR; Giacca A; Philpott DJ; Klip A
    Diabetes; 2011 Sep; 60(9):2206-15. PubMed ID: 21715553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased NOD1, but not NOD2, activity in subcutaneous adipose tissue from patients with metabolic syndrome.
    Zhou YJ; Liu C; Li CL; Song YL; Tang YS; Zhou H; Li A; Li Y; Weng Y; Zheng FP
    Obesity (Silver Spring); 2015 Jul; 23(7):1394-400. PubMed ID: 26052894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD1 activation induces innate immune responses and insulin resistance in human adipocytes.
    Zhou YJ; Zhou H; Li Y; Song YL
    Diabetes Metab; 2012 Dec; 38(6):538-43. PubMed ID: 23182460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparagine attenuates hepatic injury caused by lipopolysaccharide in weaned piglets associated with modulation of Toll-like receptor 4 and nucleotide-binding oligomerisation domain protein signalling and their negative regulators.
    Wu H; Liu Y; Pi D; Leng W; Zhu H; Hou Y; Li S; Shi H; Wang X
    Br J Nutr; 2015 Jul; 114(2):189-201. PubMed ID: 26079268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
    Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
    Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.
    Cavallari JF; Barra NG; Foley KP; Lee A; Duggan BM; Henriksbo BD; Anhê FF; Ashkar AA; Schertzer JD
    Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E579-E585. PubMed ID: 32101030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of genetic variations in the genes encoding NOD1 and NOD2 on type 2 diabetes mellitus and insulin resistance.
    Ozbayer C; Kurt H; Kebapci MN; Gunes HV; Colak E; Degirmenci I
    J Clin Pharm Ther; 2017 Feb; 42(1):98-102. PubMed ID: 27885704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD1 and NOD2 stimulation triggers innate immune responses of human periodontal ligament cells.
    Jeon DI; Park SR; Ahn MY; Ahn SG; Park JH; Yoon JH
    Int J Mol Med; 2012 Apr; 29(4):699-703. PubMed ID: 22218461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription of NOD1 and NOD2 and their interaction with CARD9 and RIPK2 in IFN signaling in a perciform fish, the Chinese perch,
    Peng XY; Wang KL; Li L; Li B; Wu XY; Zhang ZW; Li N; Liu LH; Nie P; Chen SN
    Front Immunol; 2024; 15():1374368. PubMed ID: 38715616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma.
    Wong CK; Hu S; Leung KM; Dong J; He L; Chu YJ; Chu IM; Qiu HN; Liu KY; Lam CW
    Cell Mol Immunol; 2013 Jul; 10(4):317-29. PubMed ID: 23524653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
    Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
    Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of conformationally constrained γ-D-glutamyl-meso-diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1).
    Jakopin Ž; Gobec M; Kodela J; Hazdovac T; Mlinarič-Raščan I; Sollner Dolenc M
    Eur J Med Chem; 2013 Nov; 69():232-43. PubMed ID: 24044936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).
    Cheng G; Sun J; Fridlender ZG; Wang LC; Ching LM; Albelda SM
    J Biol Chem; 2010 Apr; 285(14):10553-62. PubMed ID: 20118240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide-binding oligomerization domain (NOD) plays an important role in neonatal infection.
    Chen Y; Yu SL; Li YP; Zhang MM
    Int J Biol Macromol; 2019 Jan; 121():686-690. PubMed ID: 30321637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages.
    Takahashi Y; Isuzugawa K; Murase Y; Imai M; Yamamoto S; Iizuka M; Akira S; Bahr GM; Momotani E; Hori M; Ozaki H; Imakawa K
    J Vet Med Sci; 2006 May; 68(5):471-8. PubMed ID: 16757890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression and regulation of nuclear oligomerization domain proteins NOD1 and NOD2 in human endometrium: a potential role in innate immune protection and menstruation.
    King AE; Horne AW; Hombach-Klonisch S; Mason JI; Critchley HO
    Mol Hum Reprod; 2009 May; 15(5):311-9. PubMed ID: 19273470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.
    Kvarnhammar AM; Petterson T; Cardell LO
    Immunology; 2011 Nov; 134(3):314-25. PubMed ID: 21978001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern-recognition receptor nucleotide-binding oligomerization domain--containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts.
    Yokota K; Miyazaki T; Hemmatazad H; Gay RE; Kolling C; Fearon U; Suzuki H; Mimura T; Gay S; Ospelt C
    Arthritis Rheum; 2012 May; 64(5):1329-37. PubMed ID: 22143988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue.
    Dagil YA; Arbatsky NP; Alkhazova BI; L'vov VL; Mazurov DV; Pashenkov MV
    PLoS One; 2016; 11(8):e0160784. PubMed ID: 27513337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.